Recent advances in engineering prodrug-based nanomedicines for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in engineering prodrug-based nanomedicines for cancer therapy

Published:2024 Issue:11 Volume:5 Page:4634-4659
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Shi Linlin¹^ORCID,Lin Shanshan²,Zhou Fengping¹,Jiang Hao¹,Zhang Jin¹

Affiliation:

1. Department of Hematology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, P. R. China

2. Department of General Practice, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, P. R. China

Abstract

This review focuses on updates regarding a broad spectrum of fabrication advances and applications in the field of prodrug-based nanotechnologies in multiple cancer therapeutic strategies in response to the tumor microenvironment.

Funder

Zhejiang University

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MA/D3MA01132A

Reference165 articles.

1. Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization

2. Functionalized nanoparticles: Tailoring properties through surface energetics and coordination chemistry for advanced biomedical applications

3. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

4. Dynamic intracellular exchange of nanomaterials’ protein corona perturbs proteostasis and remodels cell metabolism

5. Tumor Abnormality-Oriented Nanomedicine Design

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP